Quick Answer
BIOADAPTIVES, INC. reported Gross Profit of $4.0 thousand for the year ending 2024.
- BIOADAPTIVES, INC. showed a decrease of -62.8% in Gross Profit from 2023 to 2024.
- This data is from BIOADAPTIVES, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $6.1 thousand | Q2 2019: $3.7 thousand | Q3 2019: $1.6 thousand | Q1 2020: $3.3 thousand | Q2 2020: $147.00 | Q3 2020: $1.1 thousand | Q1 2021: $2.5 thousand | Q2 2021: $3.4 thousand | Q3 2021: $3.1 thousand | Q1 2022: $1.9 thousand | Q2 2022: $2.2 thousand | Q3 2022: $2.0 thousand | Q1 2023: $2.0 thousand | Q2 2023: $1.5 thousand | Q3 2023: $4.7 thousand | Q1 2024: $3.6 thousand | Q2 2024: $429.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $1.1 thousand | Q3 2025: $3.9 thousand.
- Over the full 6 years of available data (2019 to 2024), BIOADAPTIVES, INC.'s Gross Profit has declined by 17.5%.
- Historical annual values: Fiscal year 2024: $4.0 thousand | Fiscal year 2023: $10.8 thousand | Fiscal year 2022: $7.1 thousand | Fiscal year 2021: $10.1 thousand | Fiscal year 2020: $6.1 thousand | Fiscal year 2019: $4.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: